Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1+17819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Sofosbuvir impurity N | C20H25FN3O9P | 1394157-34-6 | Details |
| Soluble epoxide hydrolase inhibitor | C18H12F5N5O3 | 1241826-88-9 | Details |
| Sootepin D | C31H48O4 | 1154518-97-4 | Details |
| Solifenacin D5 hydrochloride | C23H22D5ClN2O2 | 1426174-05-1 | Details |
| Sofosbuvir impurity G | C22H29FN3O9P | 1337482-15-1 | Details |
| Sofosbuvir impurity J | C22H30FN4O8P | 1334513-10-8 | Details |
| Sofosbuvir impurity K | C22H29ClN3O9P | 1496552-51-2 | Details |
| Sofosbuvir impurity M | C22H30N3O10P | 2095551-10-1 | Details |
| Solenopsin | C17H35N | 137038-57-4 | Details |
| Solanidine | C27H43NO | 80-78-4 | Details |
| Solabegron | C23H23ClN2O3 | 252920-94-8 | Details |
| Eugenol | C10H12O2 | 97-53-0 | Details |
| Spiramycin I | C43H74N2O14 | 24916-50-5 | Details |
| SPD304 dihydrochloride | C32H33ClF3N3O2 | 1049741-03-8 | Details |
| Sorafenib-d4；Bay 43-9006 (D4);Sorafenib (D4) | C21H16ClF3N4O3 | 1207560-07-3 | Details |
| Spastazoline | C20H30N8 | 2351882-11-4 | Details |
| SP-8356 | C18H20O4 | 1454885-45-0 | Details |
| Sotalol-d6 hydrochloride；Sotalol D6 hydrochloride | C12H21ClN2O3S | 1246820-85-8 | Details |
| Squalamine；MSI-1256 | C34H65N3O5S | 148717-90-2 | Details |
| SQ28603；Squibb 28603;SQ28,603 | C13H17NO3S | 100845-83-8 | Details |
| Spirodiclofen | C21H24Cl2O4 | 148477-71-8 | Details |
| Clofibrate；Clofibrato;Ethyl clofibrate;Clofibratum | C12H15ClO3 | 637-07-0 | Details |
| NSC-70220；SOS1-IN-1 | C22H15NO2 | 4551-00-2 | Details |
| Soraprazan；BYK61359 | C21H25N3O3 | 261944-46-1 | Details |
| SP4206 | C30H37Cl2N7O6 | 515846-21-6 | Details |
| Sparfosic acid trisodium | C6H11NNaO8P | 70962-66-2 | Details |
| SQ-31765；SQ31765;SQ 31765 | C24H27F3N2O4 | 138383-07-0 | Details |
| sPLA2-X Inhibitor 31 | C19H15F3N2O4 | 2241025-50-1 | Details |
| SPL-410 | C24H31F3N2O4S | 2351886-00-3 | Details |
| 5-HT3 antagonist 2 | C18H21N3O | 128199-93-9 | Details |
| BI-3406 | C23H25F3N4O3 | 2230836-55-0 | Details |
| SSR128129E free acid；SSR free acid | C18H16N2O4 | 848463-13-8 | Details |
| SSR-241586 | C32H42Cl2N4O3 | 1239279-30-1 | Details |
| SRT3657 | C40H54N8O6S | 1383551-17-4 | Details |
| Src Inhibitor 3 | C34H32ClFN8O4 | 2380027-49-4 | Details |
| SR121566A | C20H25N5O4S | 180144-61-0 | Details |
| Squalamine lactate；MSI-1256F | C37H71N3O8S | 320725-47-1 | Details |
| SR10067 | C31H31NO3 | 1380548-02-6 | Details |
| ST3932 | C12H16N8O | 1246018-21-2 | Details |
| ST1936 oxalate | C15H19ClN2O4 | 1782228-83-4 | Details |
| ST-193 | C24H25N3O | 489416-12-8 | Details |
| SSTC3 | C23H17F3N4O3S2 | 1242422-09-8 | Details |
| Guaiacol | C7H8O2 | 90-05-1 | Details |
| SSTR5 antagonist 1 | C28H34FN3O5 | 1628741-91-2 | Details |
| STAT3-IN-1 | C28H29NO6 | 2059952-75-7 | Details |
| Cisapride | C23H29ClFN3O4 | 81098-60-4 | Details |
| SIBA | C14H21N5O3S | 35899-54-8 | Details |
| SID 26681509 | C27H33N5O5S | 958772-66-2 | Details |
| SK1-IN-1 | C22H30N4O3 | 1218816-71-7 | Details |
| SKF-34288 hydrochloride | C6H6ClNO2S | 320386-54-7 | Details |
| SK33 | C20H13F9N2O3 | 1928724-23-5 | Details |
| Sitaxsentan | C18H15ClN2O6S2 | 184036-34-8 | Details |
| Tiapride hydrochloride | C15H25ClN2O4S | 51012-33-0 | Details |
| Sigma-1 receptor antagonist 2 | C20H26ClN3O2 | 1639220-15-7 | Details |
| SIRT-IN-2 | C15H21N5O3S2 | 1431411-66-3 | Details |
| SIRT-IN-1 | C19H27N5O2S | 1431411-60-7 | Details |
| Siomycin A | C71H81N19O18S5 | 12656-09-6 | Details |
| Sigma-1 receptor antagonist 1 | C19H23Cl2N3O | 1639220-19-1 | Details |
| SIRT5 inhibitor 1 | C31H39FN6O6S2 | 2166487-21-2 | Details |
| Sirt2-IN-1 | C28H27N7O2S2 | 1862238-00-3 | Details |
| Sitravatinib malate；MGCD516 malate;MG-516 malate | C37H35F2N5O9S | 2244864-88-6 | Details |
| SIS3 free base | C28H27N3O3 | 1009104-85-1 | Details |
| Sirtuin modulator 1 | C31H32ClN5O2S2 | 2070015-26-6 | Details |
| Silvestrol aglycone | C27H26O8 | 960365-65-5 | Details |
| Silvestrol aglycone (enantiomer) | C27H26O8 | 1112993-18-6 | Details |
| Siltenzepine | C19H20ClN3O4 | 98374-54-0 | Details |
| Siguazodan；SKF 94836 | C14H16N6O | 115344-47-3 | Details |
| SNT-207707 | C32H44ClN5O | 1064662-40-3 | Details |
| SN50 | C129H230N36O29S | 213546-53-3 | Details |
| SMYD3-IN-1 | C28H31ClN4O3 | 2095160-79-3 | Details |
| Fleroxacin | C17H18F3N3O3 | 79660-72-3 | Details |
| Sofosbuvir impurity C | C22H29FN3O9P | 1496552-28-3 | Details |
| 4-Aminosalicylic acid；Aminopar;Aminosalicylic acid;para-aminosalicylic acid;4-aminosalicylate | C7H7NO3 | 65-49-6 | Details |
| Sofosbuvir impurity F；Sofosbuvir 3',5'-Bis-(S)-phosphate | C34H45FN4O13P2 | 1337482-17-3 | Details |
| PSI-7976 | C22H29FN3O9P | 1190308-01-0 | Details |
| Sodium Channel inhibitor 1 | C24H19F4N3O3 | 1198117-23-5 | Details |
| Sofosbuvir impurity A | C22H29FN3O9P | 1496552-16-9 | Details |
| SNT-207858 | C32H45Cl4N5O3 | 1104080-42-3 | Details |
| SOCE inhibitor 1 | C25H22F3N5O4 | 2169316-15-6 | Details |
| SNT-207858 free base | C32H43Cl2N5O3 | 1104662-66-9 | Details |
| Sodium formononetin-3'-sulfonate；Sul-F | C15H9NaO7S | 949021-68-5 | Details |
| Sodium Channel inhibitor 2 | C26H25Cl2N3O | 653573-60-5 | Details |
| Sodium citrate dihydrate | C6H9Na3O9 | 6132-04-3 | Details |
| Sodium copper chlorophyllin B | C34H29CuN4NaO7(-2) | 28302-36-5 | Details |
| SNDX-5613 | C32H47FN6O4S | 2169919-21-3 | Details |
| SN 2 | C17H21NO | 823218-99-1 | Details |
| SM-276001 | C16H21N7O | 473930-22-2 | Details |
| SLC13A5-IN-1 | C19H19Cl3N2O3S | 2227548-95-8 | Details |
| SMP-028 | C23H26FN5O2S | 914389-14-3 | Details |
| SMS2-IN-1 | C34H37F6N3O5 | 2098890-15-2 | Details |
| SMYD2-IN-1 | C25H25Cl2F2N7O2 | 2023788-96-5 | Details |
| SMS1-IN-1 | C23H23BrN2O4S | 1807943-38-9 | Details |
| SMAP-2；DT-1154 | C27H27F3N2O4S | 1809068-70-9 | Details |
| SMN-C3 | C24H28N6O | 1449597-34-5 | Details |
| SKF89976A hydrochloride | C22H26ClNO2 | 85375-15-1 | Details |
| Gatifloxacin | C19H22FN3O4 | 112811-59-3 | Details |
| SJB3-019A | C16H8N2O3 | 2070015-29-9 | Details |
| Sigma-1 receptor antagonist 3 | C19H23ClFN3O | 1639220-17-9 | Details |
| 3-Pyridinemethanol | C6H7NO | 100-55-0 | Details |
| Sodium laureth sulfate | (C2H4O)nC12H26O4S.Na | 9004-82-4 | Details |
| Product Total： Product Page： | ||||
| 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 | ||||